TAGRISSO® (osimertinib) Patient Work

Below is an ad that went live during Lung Cancer Awareness Month, as well as the revamped TAGRISSO® (osimertinib) site.

Here is a little bit of information to guide you through the following ads:

Many non-small cell lung cancer patients believe that surgery will “cure” their cancer and are resistant to the idea of receiving therapy after surgery. Given this desire to be “done,” people with early-stage disease are not motivated to do research and are very dependent on their primary health provider- following their lead when it comes to treatment. This audience also looks to their caregivers as well as people with similar experiences to educate them on their journey, often turning to social media channels as a resource to get this information.